OUC

OUC Marine Pharmaceutical is a prominent Chinese biopharmaceutical company dedicated to the discovery and development of marine-derived therapeutics. As the commercial and industrialization arm of the Ocean University of China (OUC), the company has established itself as a global leader in marine carbohydrate medicine. Its portfolio includes PSS (Propylene Glycol Alginate Sodium Sulfate), the first marine drug approved in China for cardiovascular conditions, and Oligomannate (GV-971), a novel oligosaccharide treatment for Alzheimer's disease. The company utilizes a specialized platform to explore the therapeutic potential of marine resources, focusing on indications in neurology, oncology, and metabolic health. OUC Marine Pharmaceutical integrates advanced R&D with large-scale manufacturing to bring innovative marine biologics and small molecules to the market.